MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-06-0037442
Medi Xpert India Limited
Medi Xpert India Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.41 Cr
▼ 55% YoY
Net loss · FY 2025
₹3.53 Cr
Net margin -20.3%
EBITDA · FY 2025
-₹2.85 Cr
EBITDA margin -16.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered
About Medi Xpert India Limited
Data last updated:
Medi Xpert India Limited is a public limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 July 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2008PLC181020. Its GSTIN is 07AAECR1202J2ZP (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It was formerly known as Roussel Pharma Limited. It is led by directors including Suresh Kumar Bharatia and Husain Baquar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ga – 13 Basement And First Floor Area Measuring 220 Sq., Mtrs. Sanjay Gandhi Transport Nagar New Delhi, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.41 Cr, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹3.53 Cr (net margin -20.3%) and EBITDA of -₹2.85 Cr (EBITDA margin -16.4%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 14% over five years.
Court records list 18 cases involving the company, including 9 filed by the company and 9 filed against it; 5 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹95.6 Lakh; the latest was in September 2018. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 1 smaller; the largest is Deependrugs Private Limited with revenue of ₹17.68 Cr.
Medi Xpert India Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0037442). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33110DL2008PLC181020
Registration Number 181020
Incorporation Date 17 July 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-06-0037442
Recognitions & Rankings of Medi Xpert India
Contact details
Medi Xpert India Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGa – 13 Basement And First Floor Area Measuring 220 Sq., Mtrs. Sanjay Gandhi Transport Nagar New Delhi, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medi Xpert India Limited, buy the company report.
Comprehensive company report
Medi Xpert India Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medi Xpert India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medi Xpert India Limited, buy the company report.
Financials of Medi Xpert India Limited
FY 2024 filings availableMedi Xpert India Limited reported revenue of ₹17.41 Cr (down 55% YoY) for FY 2025.
Revenue · FY 2025
₹17.41 Cr ▼ 55%
Net loss · FY 2025
₹3.53 Cr margin -20.3%
EBITDA · FY 2025
-₹2.85 Cr margin -16.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 55%
3 years · compounded
▼ 45%
5 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▼ 109%
3 years · compounded
▼ 71%
5 years · compounded
▼ 48%
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 55% fall in the latest year. EBITDA fell 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.53 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -16.4% | ||||
| Net Profit Margin | -20.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medi Xpert India Limited, buy the company report.
Board of directors of Medi Xpert India Limited
Medi Xpert India has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Bharatia | Director | 17 Jul 2008 | 18 Years 3 Months | Current |
| Husain Baquar | Director | 05 May 2015 | 11 Years 5 Months | Current |
| Vishnu Halwai | Director | 21 May 2012 | 14 Years 5 Months | Current |
Peer comparison
Medi Xpert India Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Deependrugs Private Limited | ₹17.68 Cr (FY 2025) | -30.0% | Ahmedabad, Gujarat, India | |||
| Mangal Medical Agencies Private Limited | ₹17.53 Cr (FY 2024) | 5.0% | Mumbai, Maharashtra, India | |||
| Sreeparna Pharmaceutical Distributors Private Limited | ₹17.5 Cr (FY 2025) | 22.0% | Malappuram, Kerala, India | |||
| Adonis Laboratories Private Limited | ₹17.49 Cr (FY 2025) | -9.0% | Mumbai, Maharashtra, India | |||
| Medi Xpert India Limitedthis company | ₹17.41 Cr (FY 2025) | -₹3.53 Cr | -20.3% | -55.0% | Delhi, India | |
| Shrrishti Healthcare Products India Private Limited | ₹17.21 Cr (FY 2025) | 0.0% | Salem, Tamil Nadu, India |
To see the full peer comparison of Medi Xpert India Limited, buy the company report.
Auditor
Medi Xpert India Limited is audited by R BHARGAVA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R BHARGAVA & ASSOCIATES | FY 2023 | 012788N |
Shareholding
The shareholding of Medi Xpert India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medi Xpert India Limited, buy the company report.
Deals & funding
Medi Xpert India Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹95.6 Lakh; the latest was in September 2018.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹95.6 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Jan 2012 | Funding round | ₹95.6 Lakh | Investors: 4 individuals |
| Nov 2008 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Medi Xpert India Limited has 18 court cases on record: 9 filed by Medi Xpert India, 9 filed against it. 5 cases are pending and 13 are disposed.
Total cases
18
Filed by the company
9
Filed against the company
9
Pending
5
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 9 | 5 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Valsad, Gujarat | Commercial matter | Filed against the company by M/S. Arihantanam Life Care Pvt. Ltd., | Pending |
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed against the company by M/S Psychotropics India Ltd. | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Magma Fincorp Limited | Pending |
| District court, South East, Delhi | Criminal case | Filed by the company against Soul Health Care (I) Pvt Ltd | Disposed |
| District court, North West, Delhi | Civil suit | Filed against the company by Seagull Pharmaceuticals Pvt Ltd. and 1 other | Disposed |
To see the full case history of Medi Xpert India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medi Xpert India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medi Xpert India has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECR1202J2ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medi Xpert India Limited, buy the company report.
Recent activity
Medi Xpert India Limited has 10 board changes on record since 2008: 3 appointments and 7 cessations. The latest: Husain Baquar ceased to be Director on 29 Sep 2015.
AGM
Medi Xpert India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Medi Xpert India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Husain Baquar ceased to be Director.
Appointed
Husain Baquar was appointed as Director.
Ceased
Vishwambhar Dayal Bhartia ceased to be Director.
Ceased
Jitendra Kumar Pandit ceased to be Director.
Ceased
Mahesh Kumar Bhartia ceased to be Director.
Ceased
Vishnu Halwai ceased to be Additional Director.
Ceased
Piyush Bhartia ceased to be Additional Director.
Appointed
Vishnu Halwai was appointed as Director.
Ceased
Zubair Ahmad ceased to be Director.
Appointed
Suresh Kumar Bharatia was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Medi Xpert India is an active public limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 July 2008 (18+ years old) and is registered under CIN U33110DL2008PLC181020.
Medi Xpert India has 3 current directors:
- Suresh Kumar Bharatia - Director
- Husain Baquar - Director
- Vishnu Halwai - Director
The latest financial statements of Medi Xpert India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Medi Xpert India is 07AAECR1202J2ZP, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Medi Xpert India is U33110DL2008PLC181020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medi Xpert India has 18 court cases on record: 9 filed by the company and 9 filed against it. 5 are pending. Most are in the district courts.
Medi Xpert India was incorporated on 17 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Medi Xpert India has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹95.6 Lakh; the latest was in September 2018.
The peers of Medi Xpert India by revenue are Deependrugs Private Limited, Mangal Medical Agencies Private Limited, Sreeparna Pharmaceutical Distributors Private Limited, Adonis Laboratories Private Limited, Shrrishti Healthcare Products India Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Husain Baquar ceased to be Director on 29 Sep 2015. Husain Baquar was appointed as Director on 05 May 2015. Vishwambhar Dayal Bhartia ceased to be Director on 05 May 2015. Medi Xpert India has 10 board changes on record in total.
Yes, Medi Xpert India is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-06-0037442).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages